233 related articles for article (PubMed ID: 19815038)
1. Temperature-dependent transfer of amphotericin B from liposomal membrane of AmBisome to fungal cell membrane.
Shimizu K; Osada M; Takemoto K; Yamamoto Y; Asai T; Oku N
J Control Release; 2010 Jan; 141(2):208-15. PubMed ID: 19815038
[TBL] [Abstract][Full Text] [Related]
2. [Liposomal amphotericin B].
Fukasawa M
Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):229-31. PubMed ID: 16282964
[TBL] [Abstract][Full Text] [Related]
3. Fungal fatal attraction: a mechanistic review on targeting liposomal amphotericin B (AmBisome
Soo Hoo L
J Liposome Res; 2017 Sep; 27(3):180-185. PubMed ID: 28805117
[TBL] [Abstract][Full Text] [Related]
4. AmBisome targeting to fungal infections.
Adler-Moore J
Bone Marrow Transplant; 1994; 14 Suppl 5():S3-7. PubMed ID: 7703928
[TBL] [Abstract][Full Text] [Related]
5. AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience.
Adler-Moore J; Proffitt RT
J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():21-30. PubMed ID: 11801577
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro studies on liposomal formulations of amphotericin B and its derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME).
Cybulska B; Kupczyk K; Szlinder-Richert J; Borowski E
Acta Biochim Pol; 2002; 49(1):67-75. PubMed ID: 12136958
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence studies on the molecular action of amphotericin B on susceptible and resistant fungal cells.
Haynes MP; Chong PL; Buckley HR; Pieringer RA
Biochemistry; 1996 Jun; 35(24):7983-92. PubMed ID: 8672502
[TBL] [Abstract][Full Text] [Related]
8. How do sterols determine the antifungal activity of amphotericin B? Free energy of binding between the drug and its membrane targets.
Neumann A; Baginski M; Czub J
J Am Chem Soc; 2010 Dec; 132(51):18266-72. PubMed ID: 21126070
[TBL] [Abstract][Full Text] [Related]
9. Modulation of amphotericin B membrane interaction by cholesterol and ergosterol--a molecular dynamics study.
Czub J; Baginski M
J Phys Chem B; 2006 Aug; 110(33):16743-53. PubMed ID: 16913814
[TBL] [Abstract][Full Text] [Related]
10. The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles.
Walker L; Sood P; Lenardon MD; Milne G; Olson J; Jensen G; Wolf J; Casadevall A; Adler-Moore J; Gow NAR
mBio; 2018 Feb; 9(1):. PubMed ID: 29437927
[TBL] [Abstract][Full Text] [Related]
11. AmBisome: relationship between the pharmacokinetic characteristics acquired by liposomal formulation and safety/efficacy.
Takemoto K; Kanazawa K
J Liposome Res; 2017 Sep; 27(3):186-194. PubMed ID: 27328721
[TBL] [Abstract][Full Text] [Related]
12. Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability.
Morand K; Bartoletti AC; Bochot A; Barratt G; Brandely ML; Chast F
Int J Pharm; 2007 Nov; 344(1-2):150-3. PubMed ID: 17669608
[TBL] [Abstract][Full Text] [Related]
13. AmBisome and Amphotericin B inhibit the initial adherence of Candida albicans to human epithelial cell lines, but do not cause yeast detachment.
Dorocka-Bobkowska B; Düzgüneş N; Konopka K
Med Sci Monit; 2009 Sep; 15(9):BR262-9. PubMed ID: 19721394
[TBL] [Abstract][Full Text] [Related]
14. Molecular organization of antifungal antibiotic amphotericin B in lipid monolayers studied by means of Fluorescence Lifetime Imaging Microscopy.
Gruszecki WI; Luchowski R; Gagoś M; Arczewska M; Sarkar P; Hereć M; Myśliwa-Kurdziel B; Strzałka K; Gryczynski I; Gryczynski Z
Biophys Chem; 2009 Jul; 143(1-2):95-101. PubMed ID: 19457605
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction between amphotericin B and ergosterol in lipid bilayers as revealed by 2H NMR spectroscopy.
Matsumori N; Tahara K; Yamamoto H; Morooka A; Doi M; Oishi T; Murata M
J Am Chem Soc; 2009 Aug; 131(33):11855-60. PubMed ID: 19645473
[TBL] [Abstract][Full Text] [Related]
16. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
Charvalos E; Tzatzarakis MN; Van Bambeke F; Tulkens PM; Tsatsakis AM; Tzanakakis GN; Mingeot-Leclercq MP
J Antimicrob Chemother; 2006 Feb; 57(2):236-44. PubMed ID: 16361329
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the fungicidal activity of amphotericin B by allicin: effects on intracellular ergosterol trafficking.
Ogita A; Fujita K; Tanaka T
Planta Med; 2009 Feb; 75(3):222-6. PubMed ID: 19053016
[TBL] [Abstract][Full Text] [Related]
18. Development of liposomal amphotericin B formulation.
Gulati M; Bajad S; Singh S; Ferdous AJ; Singh M
J Microencapsul; 1998; 15(2):137-51. PubMed ID: 9532520
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of AmBisome and non-liposomal amphotericin B following uptake of Candida glabrata by murine epidermal Langerhans cells.
Sperry PJ; Cua DJ; Wetzel SA; Adler-Moore JP
Med Mycol; 1998 Jun; 36(3):135-41. PubMed ID: 9776826
[TBL] [Abstract][Full Text] [Related]
20. Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4.
Bellocchio S; Gaziano R; Bozza S; Rossi G; Montagnoli C; Perruccio K; Calvitti M; Pitzurra L; Romani L
J Antimicrob Chemother; 2005 Feb; 55(2):214-22. PubMed ID: 15649994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
